Actively Recruiting
The Early Warning System for the Diabetic Encephalopathy
Led by Tang-Du Hospital · Updated on 2022-07-13
300
Participants Needed
1
Research Sites
608 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Diabetes( mainly type II diabetes )lead to the central nervous system (CNS) function impairment, especially the mild cognitive impairment that increased the risk of progression to dementia.The primary objectives are defined according to a hierarchical design: i) to tailor and apply multi-parametric, functional MRI techniques to identify cerebral abnormalities (cerebral biomarkers) in type 2 diabetes mellitus and prodromal diabetes mellitus ; ii) to assess whether these cerebral biomarkers are associated with cognitive decrements;iii) to follow up with the putative prediabetic condition patients to verify whether they can transform into diabetes.
CONDITIONS
Official Title
The Early Warning System for the Diabetic Encephalopathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- No diagnosis of dementia
- Signed informed consent form
- Education of more than 6 years
- Blood glucose levels meet the group standard
You will not qualify if you...
- Pregnant women
- Serious brain diseases
- Contraindications to magnetic resonance imaging
- Lack of compliance
- Poor image quality that cannot be analyzed
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tangdu Hospital
Xi'an, Shaanxi, China, 710032
Actively Recruiting
Research Team
G
Guangbin Cui, professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here